BSAM
CRL icon

Blue Sky Asset Management’s Charles River Laboratories CRL Stock Holding History

Blue Sky Asset Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-10,472
Closed -$942K – 91
2017
Q1 		$942K Buy
+10,472
New +$889K 0.57% 30

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Blue Sky Asset Management's CRL Position: Q2 2017 in Review

Blue Sky Asset Management sold out of Charles River Laboratories (CRL) in Q2 2017, closing a stake of 10,472 shares — an estimated $942K sold.

Blue Sky Asset Management first reported a position in CRL in Q1 2017 and held it in 1 quarter. The position peaked at $942K in Q1 2017. 302 funds tracked by Wall St. Rank hold CRL as of Q2 2017.

  • Blue Sky Asset Management reported no remaining Charles River Laboratories position as of Q2 2017 after selling out during the quarter.
  • Blue Sky Asset Management sold 10,472 Charles River Laboratories shares in Q2 2017, an estimated $942K.
  • Blue Sky Asset Management first reported a position in Charles River Laboratories in Q1 2017 and held it in 1 quarter.
  • Blue Sky Asset Management's Charles River Laboratories position peaked at $942K in Q1 2017.
  • 302 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2017.

Based on Blue Sky Asset Management's 13F filing for Q2 2017, filed 1 Aug 2017.